Core Viewpoint - The article discusses the lack of positions held by Parkev Tatevosian, CFA, and The Motley Fool in the mentioned stocks, emphasizing their disclosure policy and potential compensation for promoting services [1] Group 1 - Parkev Tatevosian has no position in any of the stocks mentioned [1] - The Motley Fool also has no position in any of the stocks mentioned [1] - The disclosure policy of The Motley Fool is highlighted, indicating transparency in their operations [1]

Core Insights - Clorox Professional has entered into a new contract with Vizient, enhancing its product solutions for healthcare and commercial cleaning sectors [1][2] - The contract, effective from May 1, 2025, aims to provide a wide range of cleaning and disinfecting solutions, including products from well-known brands like Clorox Healthcare and Pine-Sol [2] Company Overview - Clorox Professional, a unit of The Clorox Company, has a 110-year legacy in supporting healthcare professionals with cleaning and disinfecting solutions [2] - The company offers recognized brands for commercial cleaning, catering to various facilities such as offices, schools, and hospitals [3] - The Clorox Company, headquartered in Oakland, California, has been a pioneer in integrating ESG into its business reporting and was ranked No. 1 on Barron's 100 Most Sustainable Companies list in 2025 [4]

Core Viewpoint - Clorox's recent quarterly report revealed disappointing sales and earnings, leading to a decline in stock price and a revised outlook for the fiscal year [2][4][6]. Financial Performance - Clorox reported non-GAAP adjusted earnings per share of $1.45 and sales of $1.67 billion for fiscal Q3, missing analyst estimates by $0.11 per share and falling short of sales expectations by $50 million [4]. - Year-over-year sales decreased by 7.7%, while earnings per share dropped by 15%. Despite an increase in gross margin from 42.2% to 44.6%, it was insufficient to counterbalance the sales decline [5]. Future Guidance - The company now anticipates sales for the fiscal year to be down 1% to flat, a revision from previous guidance of down 1% to up 2%. Organic sales growth is projected to be between 4% and 5%, down from earlier expectations of 4% to 7% [6]. - Clorox maintained its adjusted earnings per share guidance for the year at $6.95 to $7.35, with a likelihood of performance aligning closer to the lower end of this range [7].

Core Insights - Clorox Company reported third-quarter fiscal 2025 results with both revenue and earnings missing Zacks Consensus Estimates and declining year-over-year [1][4] - The results reflect ongoing economic uncertainty affecting consumer shopping habits and overall sales, yet the company maintained strong fundamentals by holding market share and expanding profit margins [2][3] Financial Performance - Adjusted earnings were $1.45 per share, missing the estimate of $1.57 and down 15% from $1.71 in the same quarter last year [4] - Net sales were $1.67 billion, an 8% decline from the previous year, missing the consensus of $1.71 billion; organic sales decreased by 2% due to an unfavorable price mix [4][5] Segment Analysis - Health and Wellness segment sales increased by 3% year-over-year to $630 million, driven by a 7-point increase in volume, despite a 4-point unfavorable price mix [6] - Household segment sales fell 11% to $469 million, primarily due to a 9-point decrease in volume and a 2-point unfavorable price mix [7] - Lifestyle segment sales decreased by 3% to $306 million, attributed to a 2-point decrease in volume and a 1% unfavorable price mix [8] - International segment sales declined 15% to $263 million; however, organic sales grew by 2% when excluding the impact of Argentina and foreign exchange rates [9] Margin and Cost Management - Gross margin expanded by 240 basis points year-over-year to 44.6%, marking the 10th consecutive quarter of margin expansion, driven by cost-saving initiatives and divestitures [5][3] - The company is investing $560-$580 million over five years to upgrade technology and operations, with 70% of this amount expected to be recorded as incremental operating costs [12] Guidance and Outlook - Clorox updated its FY25 outlook, expecting net sales to decline 1% to flat, reflecting weaker consumer demand and impacts from divestitures [14] - Organic sales are anticipated to increase by 4-5%, down from a previous estimate of 4-7%, with a negative impact from the ERP system transition [14][17] - The gross margin is expected to expand by 150 basis points, driven by margin management efforts, despite cost inflation and higher promotional expenses [15] Earnings Projections - The company projects a GAAP EPS of $5.73-$6.13, indicating a year-over-year increase of 155-172% [16] - Adjusted EPS is expected to be $6.95-$7.35, reflecting a 13-19% year-over-year increase [17]

Core Viewpoint - Clorox Co's fiscal third-quarter earnings and revenue missed estimates, leading to a 2.5% decline in share price to $134.96, with profits of $1.45 per share falling below the $1.71 per share from the same quarter last year [1] Group 1: Earnings and Revenue Performance - Clorox reported fiscal third-quarter earnings of $1.45 per share, which is a decrease from $1.71 per share in the same quarter a year ago [1] - The company's revenue also missed market expectations, contributing to the decline in share price [1] Group 2: Analyst Reactions - Following the earnings report, several analysts reduced their price targets for Clorox, with Morgan Stanley lowering its target from $165 to $150 [1] - Despite the price target reductions, there have been no downgrades, as 16 out of 17 brokerages maintain a "hold" or worse rating on the stock [1] Group 3: Stock Performance and Options Activity - Clorox shares traded as low as $129.74 earlier in the day, with the $130 level providing some support against further losses, similar to trends observed in June and July [2] - Since the beginning of the year, Clorox's stock has decreased by 17% [2] - The options market has seen a significant increase in activity, with Clorox stock experiencing quadruple the typical options volume, particularly with the May 125 put being the most popular [2]

Group 1 - The Clorox Company held its Third Quarter Fiscal Year 2025 Earnings Release Conference Call, indicating a structured approach to financial reporting and investor communication [2][4] - Key participants in the call included Lisah Burhan (VP, IR), Linda Rendle (Chair and CEO), and Luc Bellet (CFO), highlighting the involvement of top management in addressing investor queries [3][4] - The call included a forward-looking statement regarding the fiscal year 2025 outlook, suggesting that management is optimistic about future performance despite potential variances from actual results [5]

Core Insights - Clorox reported $1.67 billion in revenue for the quarter ended March 2025, reflecting an 8.1% year-over-year decline and an EPS of $1.45, down from $1.71 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate by 2.67%, while the EPS also missed the consensus estimate by 7.64% [1] Financial Performance Metrics - Organic Revenue Growth in Health and Wellness was 3%, surpassing the average estimate of -1.9% [4] - Organic Revenue Growth in International was 2%, below the average estimate of 6% [4] - Organic Revenue Growth in Lifestyle was -3%, compared to the average estimate of 0.3% [4] - Organic Revenue Growth in Household was -11%, significantly lower than the average estimate of -1.5% [4] - Overall Organic Sales Growth was -2%, missing the average estimate of 1.2% [4] Revenue Breakdown - Net Revenue for Health and Wellness was $630 million, exceeding the average estimate of $597.23 million, representing a 3.5% year-over-year increase [4] - Net Revenue for International was $263 million, slightly above the average estimate of $258.40 million, but reflecting a 15.2% year-over-year decline [4] - Net Revenue for Lifestyle was $306 million, below the average estimate of $314.14 million, indicating a 2.9% year-over-year decrease [4] - Net Revenue for Household was $469 million, significantly lower than the average estimate of $515.48 million, showing a 10.8% year-over-year decline [4] Income Before Taxes - Income before income taxes for Health and Wellness was $169 million, slightly below the average estimate of $176.17 million [4] - Income before income taxes for Corporate and Other was -$55 million, better than the average estimate of -$68.49 million [4] - Income before income taxes for International was $31 million, exceeding the average estimate of $27.86 million [4] Stock Performance - Clorox shares have returned -3.3% over the past month, while the Zacks S&P 500 composite has increased by 0.4% [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Clorox (CLX) came out with quarterly earnings of $1.45 per share, missing the Zacks Consensus Estimate of $1.57 per share. This compares to earnings of $1.71 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -7.64%. A quarter ago, it was expected that this consumer products maker would post earnings of $1.39 per share when it actually produced earnings of $1.55, delivering a surprise of 11.51%.Over the last four quarters, the co ...

Financial Data and Key Metrics Changes - The company reported a tenth consecutive quarter of gross margin expansion, indicating strong fundamentals despite a challenging consumer environment [7][8] - The updated outlook reflects anticipated pressure on consumers and retailers, impacting sales growth expectations [7][8] Business Line Data and Key Metrics Changes - The household products category experienced a low single-digit decline, attributed to changing consumer spending behaviors and macroeconomic uncertainties [12][19] - The company maintained overall market shares across its portfolio, with specific categories showing resilience despite competitive pressures [7][12] Market Data and Key Metrics Changes - U.S. consumer sentiment weakened significantly in the latter half of the third quarter, leading to changes in shopping behaviors and impacting sales [7][19] - Retailers engaged in inventory destocking, particularly in the household segment, which affected sales figures [36][39] Company Strategy and Development Direction - The company remains focused on its long-term strategy, emphasizing organic sales growth and strong earnings growth despite current market challenges [8][18] - The management is actively working on mitigating tariff impacts through strategic pricing and supply chain adjustments [28][29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of its essential product categories, despite current consumer spending pressures [7][21] - The company anticipates continued challenges in the consumer environment but remains committed to navigating these uncertainties effectively [8][21] Other Important Information - The company is preparing for an ERP transition, which is expected to enhance operational efficiency and support future growth [55][59] - The management highlighted the importance of maintaining a strong balance sheet and cash flow to capitalize on potential M&A opportunities in the future [118][119] Q&A Session Summary Question: What is driving the category weakness? - Management noted that while categories typically show resilience, recent macroeconomic factors have led to a low single-digit decline in household essentials [12][19] Question: How should we think about organic sales growth given current conditions? - Management indicated that organic sales growth expectations are muted due to ongoing category softness and retailer inventory adjustments [24][88] Question: What is the expected impact of tariffs on gross margins? - The anticipated gross impact from tariffs is around $100 million annually, with efforts underway to mitigate this through various strategies [27][28] Question: Can you provide insights on promotional activity by category? - Management confirmed that promotional activity has normalized but varies by category, with some experiencing higher promotional pressures [44][46] Question: How is the ERP transition expected to impact organic sales? - The ERP transition is expected to provide a lift in organic sales, with retailers building inventory ahead of the transition to mitigate out-of-stock risks [55][59] Question: What is the company's approach to M&A in the current environment? - The company remains open to M&A opportunities but prioritizes maintaining a healthy core business and strong financial performance [118][119]

Financial Data and Key Metrics Changes - The company experienced a decline in overall market categories, with average declines in the low single digits during the third quarter [14][22] - Despite the challenges, the company maintained market shares and achieved its tenth consecutive quarter of gross margin expansion [9][10] - The gross margin for the fourth quarter is expected to be around 44%, consistent with the annual average of approximately 44.5% [40] Business Line Data and Key Metrics Changes - The household products segment faced significant competitive pressure, leading to a decline in sales, particularly in the Glad brand due to increased promotional activity [96][100] - The cleaning category showed resilience, with the company growing market share despite overall category declines [86][111] - The cat litter segment is competitive, but the company has introduced innovations that are performing well in the market [100][101] Market Data and Key Metrics Changes - Consumer sentiment weakened significantly in the second half of the third quarter, impacting shopping behaviors and leading to lower-than-expected sales [8][9] - Retailers are adjusting their inventory levels, which has resulted in some destocking, particularly in the household segment [41][44] - The company noted a shift in consumer spending towards essentials and larger purchases, impacting discretionary categories [17][78] Company Strategy and Development Direction - The company aims to continue delivering organic sales growth and strong earnings growth while navigating a challenging consumer environment [10][120] - There is a focus on innovation and maintaining a balanced portfolio that caters to both premium and value-seeking consumers [55][111] - The company is actively managing its supply chain and pricing strategies to mitigate the impact of tariffs and maintain margins [32][70] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of their essential product categories despite current economic uncertainties [9][23] - The outlook for fiscal year 2025 anticipates continued challenges, with organic sales growth expected to be muted [27][92] - The company is closely monitoring consumer behavior and market dynamics to adapt its strategies accordingly [23][120] Other Important Information - The company is preparing for an ERP transition, which is expected to enhance operational efficiency and inventory management [61][65] - There is a wide range in the sales outlook due to the volatility in consumer demand and retailer inventory adjustments [62][66] Q&A Session Summary Question: What is driving the category weakness? - Management noted that while categories are traditionally resilient, recent macroeconomic uncertainties have led to a low single-digit decline in sales [14][22] Question: How should we think about organic sales growth in the long term? - The company expects organic sales growth to be suppressed in the near term but anticipates a return to normal category growth over time [27][28] Question: What is the expected impact of tariffs on gross margin? - The anticipated gross impact from tariffs is around $100 million annually, with efforts underway to mitigate this through various strategies [31][32] Question: Can you provide insights on promotional activity by category? - Promotional activity has normalized overall, but some categories, like Glad, are experiencing higher promotional pressures due to competitive actions [50][51] Question: How is the ERP transition expected to impact sales? - The ERP transition is expected to lead to a build-up of inventory, which could translate into growth in the following quarters [65][66] Question: What is the company's approach to M&A in the current environment? - The company remains focused on strengthening its core business while exploring opportunities for portfolio improvement through M&A [120]